Related Experiment Video

Updated: Feb 26, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment

Feilong Zhou1, Fangfang Teng1,2, Peizong Deng1

  • 1School of Biological Science and Technology, University of Jinan, No. 336 West Road of Nanxinzhuang, Jinan 250022, Shandong Province, China.

Anti-Cancer Agents in Medicinal Chemistry
|July 15, 2017
PubMed

Insights

Nano-drug delivery systems enhance liver cancer treatment by improving drug delivery and bioavailability. These systems offer targeted delivery, reducing side effects for better patient outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Liver cancer poses a significant threat to human health.
  • Effective treatment strategies for liver cancer are in high demand.
  • Conventional treatments often face challenges with drug efficacy and side effects.

Purpose of the Study:

  • To review the latest advancements in liver-targeted drug delivery systems.
  • To highlight the potential of nano-drug delivery systems (NDDS) in liver cancer therapy.
  • To discuss strategies for improving drug bioavailability and reducing toxicity.

Main Methods:

  • Literature review of recent studies on NDDS for liver cancer.
  • Analysis of structural modifications and target molecule decoration in NDDS.
  • Evaluation of NDDS for selective drug delivery to liver tissue.

Main Results:

  • NDDS demonstrate improved selective drug delivery to liver tissue.
  • Enhanced bioavailability of anti-cancer drugs is achievable with NDDS.
  • NDDS modifications can significantly reduce systemic drug side effects.

Conclusions:

  • Liver-targeted drug delivery systems, particularly NDDS, show great promise for liver cancer treatment.
  • Tailored NDDS offer a viable strategy to overcome limitations of conventional therapies.
  • Further research into NDDS development is crucial for advancing liver cancer care.
Keywords:
Liver canceranticancer agent.drug delivery systempassive targetingreviewtarget molecule

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Manufacture and Drug Delivery Applications of Silk Nanoparticles09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.7K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59